The reaction of zinc(II) sulfate with ligand pmtpo and KSCN gave rise to a supramolecular complex, [Zn(pmtpo)2(NCS)2], (Pmtpo = 2-(2-pyridylmethylthio)-5-(4-pyridyl)-1,3,4-oxadiazole), which was characterized by X-ray diffraction analysis, UV and IR spectra. This complex is crystallized in a monoclinic space group C2/c and in the complex crystal structure, the center Zn(II) ion has a tetrahedron coordination environment. The structure is extended by weak (4-pyridyl)C–H…SCN− hydrogen bonding and two-sorted weak π −π packing interactions. The fluorescent property and thermal stability of the complex are researched.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: